Cargando…

Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer

SIMPLE SUMMARY: The five times sit to stand (5STS) test is widely used to measure functional lower extremity strength. However, the psychometric properties of the 5STS test when performed remotely is unknown. This study determined the feasibility, reliability, and safety of the remote five times sit...

Descripción completa

Detalles Bibliográficos
Autores principales: Steffens, Daniel, Pocovi, Natasha C., Bartyn, Jenna, Delbaere, Kim, Hancock, Mark J., Koh, Cherry, Denehy, Linda, van Schooten, Kimberley S., Solomon, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177509/
https://www.ncbi.nlm.nih.gov/pubmed/37173899
http://dx.doi.org/10.3390/cancers15092434
_version_ 1785040655138947072
author Steffens, Daniel
Pocovi, Natasha C.
Bartyn, Jenna
Delbaere, Kim
Hancock, Mark J.
Koh, Cherry
Denehy, Linda
van Schooten, Kimberley S.
Solomon, Michael
author_facet Steffens, Daniel
Pocovi, Natasha C.
Bartyn, Jenna
Delbaere, Kim
Hancock, Mark J.
Koh, Cherry
Denehy, Linda
van Schooten, Kimberley S.
Solomon, Michael
author_sort Steffens, Daniel
collection PubMed
description SIMPLE SUMMARY: The five times sit to stand (5STS) test is widely used to measure functional lower extremity strength. However, the psychometric properties of the 5STS test when performed remotely is unknown. This study determined the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) in 37 patients scheduled to undergo gastrointestinal cancer surgery. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. The study provides supporting evidence that the remote 5STS test is feasible, reliable, and safe in patients with gastrointestinal cancer and can be used in both clinical and research settings. ABSTRACT: Background: To determine the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) test in patients with gastrointestinal cancer. Methods: Consecutive adult patients undergoing surgical treatment for lower gastrointestinal cancer at a major referral hospital in Sydney between July and November 2022 were included. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. Outcomes included measures of feasibility, reliability, and safety. Results: Of fifty-five patients identified, seventeen (30.9%) were not interested, one (1.8%) had no internet coverage, and thirty-seven (67.3%) consented and completed both 5STS tests. The mean (SD) time taken to complete the face-to-face and remote 5STS tests was 9.1 (2.4) and 9.5 (2.3) seconds, respectively. Remote collection by telehealth was feasible, with only two participants (5.4%) having connectivity issues at the start of the remote assessment, but not interfering with the tests. The remote 5STS test showed excellent reliability (ICC = 0.957), with limits of agreement within acceptable ranges and no significant systematic errors observed. No adverse events were observed within either test environment. Conclusions: Remote 5STS for the assessment of functional lower extremity strength in gastrointestinal cancer patients is feasible, reliable, and safe, and can be used in clinical and research settings.
format Online
Article
Text
id pubmed-10177509
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101775092023-05-13 Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer Steffens, Daniel Pocovi, Natasha C. Bartyn, Jenna Delbaere, Kim Hancock, Mark J. Koh, Cherry Denehy, Linda van Schooten, Kimberley S. Solomon, Michael Cancers (Basel) Article SIMPLE SUMMARY: The five times sit to stand (5STS) test is widely used to measure functional lower extremity strength. However, the psychometric properties of the 5STS test when performed remotely is unknown. This study determined the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) in 37 patients scheduled to undergo gastrointestinal cancer surgery. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. The study provides supporting evidence that the remote 5STS test is feasible, reliable, and safe in patients with gastrointestinal cancer and can be used in both clinical and research settings. ABSTRACT: Background: To determine the feasibility, reliability, and safety of the remote five times sit to stand test (5STS) test in patients with gastrointestinal cancer. Methods: Consecutive adult patients undergoing surgical treatment for lower gastrointestinal cancer at a major referral hospital in Sydney between July and November 2022 were included. Participants completed the 5STS test both face-to-face and remotely, with the order randomised. Outcomes included measures of feasibility, reliability, and safety. Results: Of fifty-five patients identified, seventeen (30.9%) were not interested, one (1.8%) had no internet coverage, and thirty-seven (67.3%) consented and completed both 5STS tests. The mean (SD) time taken to complete the face-to-face and remote 5STS tests was 9.1 (2.4) and 9.5 (2.3) seconds, respectively. Remote collection by telehealth was feasible, with only two participants (5.4%) having connectivity issues at the start of the remote assessment, but not interfering with the tests. The remote 5STS test showed excellent reliability (ICC = 0.957), with limits of agreement within acceptable ranges and no significant systematic errors observed. No adverse events were observed within either test environment. Conclusions: Remote 5STS for the assessment of functional lower extremity strength in gastrointestinal cancer patients is feasible, reliable, and safe, and can be used in clinical and research settings. MDPI 2023-04-24 /pmc/articles/PMC10177509/ /pubmed/37173899 http://dx.doi.org/10.3390/cancers15092434 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Steffens, Daniel
Pocovi, Natasha C.
Bartyn, Jenna
Delbaere, Kim
Hancock, Mark J.
Koh, Cherry
Denehy, Linda
van Schooten, Kimberley S.
Solomon, Michael
Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer
title Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer
title_full Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer
title_fullStr Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer
title_full_unstemmed Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer
title_short Feasibility, Reliability, and Safety of Remote Five Times Sit to Stand Test in Patients with Gastrointestinal Cancer
title_sort feasibility, reliability, and safety of remote five times sit to stand test in patients with gastrointestinal cancer
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177509/
https://www.ncbi.nlm.nih.gov/pubmed/37173899
http://dx.doi.org/10.3390/cancers15092434
work_keys_str_mv AT steffensdaniel feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT pocovinatashac feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT bartynjenna feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT delbaerekim feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT hancockmarkj feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT kohcherry feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT denehylinda feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT vanschootenkimberleys feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT solomonmichael feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer
AT feasibilityreliabilityandsafetyofremotefivetimessittostandtestinpatientswithgastrointestinalcancer